|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/68 | |
| G01N 33/574 |
| (11) | Number of the document | 2972373 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14714119.6 |
| Date of filing the European patent application | 2014-03-12 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/024746 |
| Date | 2014-03-12 |
| (87) | Number | WO 2014/151006 |
| Date | 2014-09-25 |
| (30) | Number | Date | Country code |
| 201361802296 P | 2013-03-15 | US | |
| 201361812678 P | 2013-04-16 | US | |
| 201361829236 P | 2013-05-30 | US | |
| 201361883186 P | 2013-09-26 | US |
| (72) |
CHEN, Daniel Shin-Yu, US
HEGDE, Priti, US
KOEPPEN, Hartmut, US
KOWANETZ, Marcin, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | BIOMARKERS AND METHODS OF TREATING PD-1 AND PD-L1 RELATED CONDITIONS |
| BIOMARKERS AND METHODS OF TREATING PD-1 AND PD-L1 RELATED CONDITIONS |